Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans

Cancer Research

Volumn 66, Issue 22, 2006, Pages 10643-10646

  Rak, Janusz ^a,b   Yu, Joanne L ^b   Luyendyk, James ^c   Mackman, Nigel ^c  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLASMINOGEN ACTIVATOR INHIBITOR; PROCOAGULANT; PROMYELOCYTIC LEUKEMIA PROTEIN; SCATTER FACTOR RECEPTOR; SEMAXANIB; THALIDOMIDE; THROMBOPLASTIN;

BLOOD CLOTTING DISORDER; CANCER CELL; CANCER COAGULOPATHY; DISEASE COURSE; DRUG SCREENING; EPIGENETICS; GENE ACTIVATION; HUMAN; HYPOXIA; NONHUMAN; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; THROMBOSIS; TROUSSEAU SYNDROME; VEIN THROMBOSIS;

ANIMALS; BLOOD COAGULATION; HUMANS; MICE; NEOPLASMS; ONCOGENES; VENOUS THROMBOSIS;

EID: 33845288991     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-2350     Document Type: Review

References (23)

1. Falanga A. Thrombophila in cancer. Semin Thromb Hemost 2005;31:104-10.
2. Trousseau A. Phlegmasia alba dolens. Clinique Medicale de l'Hotel-Dieu de Paris. 2nd ed. Paris, France: The Sydenham Society; 1865. p. 654-712.
3. Dvorak FH, Rickles FR. Malignancy and Hemostasis. In: Coleman RB, Marder VJ, Clowes AW, George JN, Goldhaber SZ, editors. Hemostasis and thrombosis: basic principles and clinical practice. 5th ed. Philadelphia: Lippincott Company Williams & Wilkins; 2006. p. 851-73.
4. Petralia GA, Lemoine NR, Kakkar AK. Mechanisms of disease: the impact of antithrombotic therapy in cancer patients. Nat Clin Pract Oncol 2005;2:356-63.
5. Mackman N. Tissue-specific hemostasis in mice. Arterioscler Thromb Vasc Biol 2005;25:2273-81.
6. Zacharski LR. Malignancy as a solid-phase coagulopathy: implications for the etiology, pathogenesis, and treatment of cancer. Semin Thromb Hemost 2003;29:239-46.
7. Rak J, Klement G. Impact of oncogenes and tumor suppressor genes on deregulation of hemostasis and angiogenesis in cancer. Cancer Metastasis Rev 2000;19:93-6.
8. Rak J, Milsom C, May L, Klement P, Yu J. Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. Semin Thromb Hemost 2006;32:54-70.
9. Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med 1996;2:209-15.
10. Yu JL, May L, Lhotak V, et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 2005;105:1734-41.
11. Seto S, Onodera H, Kaido T, et al. Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis and impact on prognosis. Cancer 2000;88:295-301.
12. Rong Y, Post DE, Pieper RO, Durden DL, Van Meir EG, Brat DJ. PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. Cancer Res 2005;65:1406-13.
13. Tallman MS, Lefebvre P, Baine RM, et al. Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia. J Thromb Haemost 2004;2:1341-50.
14. Boccaccio C, Sabatino G, Medico E, et al. The MET oncogene drives a genetic programme linking cancer to haemostasis. Nature 2005;434:396-400.
15. Browder T, Folkman J, Pirie-Shepherd S. The hemostatic system as a regulator of angiogenesis. J Biol Chem 2000;275:1521-4.
16. Belting M, Ahamed J, Ruf W. Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arterioscler Thromb Vasc Biol 2005;25:1545-50.
17. Gentry PA. Comparative aspects of blood coagulation. Vet J 2004;168:238-51.
18. Tsakiris DA, Scudder L, Hodivala-Dilke K, Hynes RO, Coller BS. Hemostasis in the mouse (Mus musculus): a review. Thromb Haemost 1999;81:177-88.
19. Janson TL, Stormorken H, Prydz H. Species specificity of tissue thromboplastin. Haemostasis 1984;14:440-4.
20. Coughlin SR. Protease-activated receptors in vascular biology. Thromb Haemost 2001;86:298-307.
21. Lusis AJ. Atherosclerosis. Nature 2000;407:233-41.
22. Dewerchin M, Herault JP, Wallays G, et al. Life-threatening thrombosis in mice with targeted Arg48-to-Cys mutation of the heparin-binding domain of antithrombin. Circ Res 2003;93:1120-6.
23. Andreotti F, De LL, Renda G, et al. Circadianicity of hemostatic function and coronary vasomotion. Cardiologia 1999;44 Suppl 1:245-9.